What are the treatment options for migraines in teenagers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Migraines in Teenagers

For teenagers with migraines, first-line acute treatment should include ibuprofen, while adolescents with moderate to severe migraines should consider triptans such as sumatriptan/naproxen oral, zolmitriptan nasal, sumatriptan nasal, rizatriptan ODT, or almotriptan oral. 1

Acute Treatment Algorithm

First-Line Options

  • Ibuprofen (7.5-10 mg/kg): Most effective NSAID for pain relief in children and adolescents 1, 2
  • Acetaminophen (15 mg/kg): Safe but less evidence for efficacy compared to ibuprofen 1, 2

Second-Line Options (for adolescents with moderate-severe migraines)

  • Sumatriptan nasal spray: FDA-approved for adolescents in Europe 1, 2
  • Zolmitriptan nasal spray: FDA-approved for adolescents in Europe 1
  • Rizatriptan ODT: FDA-approved for patients aged 6-17 years in the USA 2
  • Almotriptan: FDA-approved for adolescents in the USA 2
  • Sumatriptan/naproxen combination: Effective for adolescents 2, 3

Treatment Strategies

  • Treat acute migraine early in the attack 1
  • If one triptan is ineffective, try another or a non-steroidal anti-inflammatory drug-triptan combination 1
  • For rapidly escalating headache pain, use a non-oral triptan formulation 1
  • For migraines with prominent nausea/vomiting, use non-oral triptan or add an anti-emetic 1

Preventive Treatment

Consider preventive treatments in teenagers with:

  • Frequent headaches (≥2 times per month) 4
  • Disabling headaches 1
  • Medication overuse 1
  • Reduced quality of life between attacks 4

Preventive Medication Options

  • Amitriptyline + cognitive behavioral therapy: Evidence supports this combination 1
  • Topiramate: Effective but has teratogenic potential (important for female adolescents) 1, 4
  • Propranolol: Evidence supports efficacy 1, 4

Non-Pharmacological Preventive Approaches

  • Regular sleep schedule
  • Consistent meal times
  • Adequate hydration
  • Regular physical activity
  • Stress management techniques
  • Identification and avoidance of personal triggers 4
  • Cognitive behavioral therapy and relaxation techniques 4, 5

Important Considerations and Cautions

Medication Overuse

  • Limit NSAIDs to ≤15 days/month 4
  • Limit triptans to ≤10 days/month 4

Safety Considerations

  • Triptans: Not recommended for patients younger than 18 years according to FDA labeling, though clinical guidelines support their use in adolescents 6
  • Sumatriptan: Safety and effectiveness in pediatric patients have not been established by FDA standards, though clinical guidelines recommend use in adolescents 6
  • Valproate derivatives: Avoid in female adolescents due to teratogenic potential 1, 4
  • Topiramate: Discuss teratogenic effects with female adolescents and advise on effective birth control methods and folate supplementation 1

Efficacy Considerations

  • Placebo was as effective as many studied medications in clinical trials, which should be discussed with patients and families 1
  • Triptans as a class show moderate quality evidence for efficacy in adolescents (NNT=6) 3
  • Sumatriptan plus naproxen sodium shows moderate quality evidence for efficacy in adolescents (NNT=6) 3

Monitoring and Follow-up

  • Use a headache diary to track frequency, duration, intensity, triggers, and medication response 4
  • Target 50% reduction in attack frequency for preventive therapy 4
  • Allow 6-8 weeks at therapeutic dose to assess effectiveness of preventive medications 4

By following this evidence-based approach to migraine management in teenagers, clinicians can help reduce the significant impact of migraines on quality of life and school performance in this vulnerable population.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drugs for the acute treatment of migraine in children and adolescents.

The Cochrane database of systematic reviews, 2016

Guideline

Migraine Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.